Investors

Investor Relations

TFF Pharmaceuticals, Inc. is an early-stage biopharmaceutical company focused on the development and commercialization of new inhalation products for the treatment of chronic respiratory diseases and lung conditions.


In early testing the Thin Film Freezing (TFF) proprietary platform significantly improved the solubility of drugs that have poor water solubility.

Volume:

Copyright West LLC. Minimum 15 minutes delayed.

Press Releases

October 24, 2019
AUSTIN, Texas--( BUSINESS WIRE )--TFF Pharmaceuticals, Inc. (Nasdaq: TFFP), an early-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing, or TFF, technology platform, today announced the pricing of its initial
Top